Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Rev Esp Cir Ortop Traumatol ; 66(5): T389-T396, 2022.
Article in English, Spanish | MEDLINE | ID: mdl-35843550

ABSTRACT

OBJECTIVE: To analyse the incidence and survival of patients with oligometastases (solitary and normal) when they are treated in centres that are experts in multidisciplinary approach to patients with sarcoma. MATERIAL AND METHOD: Retrospective analysis of 414 patients with bone metastases secondary to carcinomas at Hospital Universitario La Paz and Hospital MD Anderson Cancer Centre (Madrid) between May 2006 and May 2019. Metastases located in the pelvis and axial skeleton were excluded, analyzing a total of 28 patients who met the criterion for solitary metastases or oligometastases with normal criteria. The study survival estimate was carried out following the Kaplan-Meier statistical method. RESULTS: The survival of the patients following the oligometastases criteria (solitary and normal) was 53%. Breast cancer was the most prevalent and had a survival rate of more than 70%. The average age of the patients was 58 years old. DISCUSSION: Systemic treatments in cancer treatment have managed to improve disease-free survival curves and lead us to redirect on the paradigm for the treatment of oligometastases, stating that treatment should be carried out in the centres that are experts in the treatment of sarcomas. CONCLUSIONS: The choice of surgical treatment for patients with oligometastases in the strict sense (solitary) and normal should be evaluated by multidisciplinary teams according to the prognoses of the patient, anatomical location and histotype of the neoplasm.

2.
Clin. transl. oncol. (Print) ; 11(11): 770-772, nov. 2009. ilus
Article in English | IBECS | ID: ibc-123710

ABSTRACT

Desmoplastic small round cell tumor is a very rare neoplasm, that usually appears in children and young adolescents. There is no standard therapy, and responses to chemotherapy are infrequent. Surgery is still the main treatment for this disease. We report the case of a 39 year-old man and briefly summarize the evidence about this tumor (AU)


No disponible


Subject(s)
Male , Adult , Humans , Peritoneal Neoplasms/diagnosis , Peritoneal Neoplasms/drug therapy , Sarcoma, Ewing/diagnosis , Disease Progression , Sarcoma, Ewing/drug therapy , Sarcoma, Small Cell/complications , Sarcoma, Small Cell/diagnosis , Sarcoma, Small Cell/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Fatal Outcome , Lymph Nodes/pathology , Neoplasm Metastasis , Peritoneal Neoplasms/pathology , Peritoneum/pathology , Prognosis , Sarcoma, Ewing/pathology , Sarcoma, Small Cell/pathology , Treatment Outcome
3.
Med. paliat ; 15(5): 273-278, nov.-dic. 2008. tab
Article in Spanish | IBECS | ID: ibc-60726

ABSTRACT

Objetivo: la prevalencia del síndrome de burnout en profesionales sanitarios que trabajan en unidades de Cuidados Paliativos de la Comunidad de Madrid, dentro del ámbito de la sanidad pública y concertada. Métodos: estudio transversal descriptivo realizado entre personal médico y de enfermería de unidades de atención domiciliaria (equipos de soporte -ESAD- y unidades de la AECC) y servicios de cuidados paliativos de hospitales de la red pública y concertada. De un total de 193 individuos, mediante muestreo aleatorio simple se seleccionó un grupo de 60, a los cuales se administró el cuestionario Maslach Burnout Inventory (MBI),validado en castellano. Fue enviado por correo en febrero 2005. El MBI consta de tres subescalas (cansancio emocional -CE-, despersonalización -DP- y realización personal -RP-). Se tuvieron en cuenta variables de tipo demográfico y laboral. Resultados: la tasa de respuestas fue del 75% (45 personas). Un 57,8% de los individuos presentaba cansancio emocional bajo, 68,9% despersonalización baja y 62,2% realización personal alta. Además un tercio de los participantes (15) se ajustaba al patrón de bajo nivel de burnout en las tres subescalas (es decir, CE bajo, DP baja y RP elevada). Conclusiones: los profesionales de Cuidados Paliativos de la Comunidad de Madrid han manifestado niveles bajos de desgaste profesional en relación con otros estudio realizados en nuestro país, fundamentalmente en atención primaria (AU)


Aim: to study the prevalence of burnout syndrome in health professionals working in palliative care units within Madrid region's public and semi-public health system. Methods: a cross-sectional descriptive study of home care medical and nursing staff -medical support team (ESAD), and also the Spanish Association Against Cancer (AECC) and palliative care services from public and semi-public hospitals. By means of simple random sampling 60 subjects were selected from a total group of 193 people. They were sent a questionnaire by mail in February 2005, the Maslach Burnout Inventory (MBI) as validated in the Spanish language. MBI has three sub-stages: emotional exhaustion (EE), depersonalitazion (DP), and personal accomplishment (PA). Not only demographic but also professional variables were taken into account. Results: response rate was 75% (45 out of 60 subjects); 57.8% showed low emotional exhaustion, 68.9% had low depersonalization, and 62.2% reported high personal accomplishment. Moreover, one third of participants(15) conform to the pattern of low burnout level in the three different substages, that is, low CE, low DP, and high RP. Conclusions: in comparison to other studies in our country, Madrid's professional palliative care staff exhibited low burnout levels (AU)


Subject(s)
Humans , Burnout, Professional/epidemiology , Stress, Psychological/epidemiology , Palliative Care , Job Satisfaction , 16360 , Health Surveys
4.
Occup Med (Lond) ; 58(7): 509-11, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18667388

ABSTRACT

BACKGROUND: Breast cancer survivors can have problems in returning to work. However, the importance of work to cancer survivors has until recently received little attention. AIMS: To investigate employment- and work-related disability in a cohort of breast cancer patients to identify possible discrimination and other obstacles to remaining in work. METHODS: Questionnaire study of breast cancer patients employed at diagnosis and where diagnosis had been confirmed at least 6 months before the interview. Participants completed a questionnaire concerning cancer-related symptoms and work-related factors and clinical details were obtained from their medical records. RESULTS: The study included 96 consecutive patients with breast cancer aged between 18 and 65 years. In total, 80% of patients were unable to work after diagnosis, but 56% returned to work at the end of treatment. The sequelae of the disease or its treatment and the stage of disease were independently associated with the ability to work after the end of treatment. Only one patient did not tell his/her employers and coworkers about his/her disease. In total, 29% noticed changes in their relation with co-workers and managers, usually in the sense that they tried to be helpful. None reported job discrimination. CONCLUSION: Breast cancer survivors in this study encountered some problems in returning to work, mainly linked to the sequelae of their disease and its treatment rather than to discrimination by employers or colleagues.


Subject(s)
Breast Neoplasms/rehabilitation , Employment/statistics & numerical data , Adolescent , Adult , Aged , Cohort Studies , Female , Humans , Middle Aged , Spain , Work Capacity Evaluation , Young Adult
5.
Clin. transl. oncol. (Print) ; 10(2): 111-116, feb. 2008. tab, ilus
Article in English | IBECS | ID: ibc-123417

ABSTRACT

INTRODUCTION: Hepatic toxicity of breast cancer therapy is well known, usually consisting of elevation in the serum levels of hepatic enzymes or fatty infiltration of the liver. The chemotherapeutic agents most commonly linked to hepatotoxic effects are methotrexate, anthracyclines, taxanes and cyclophosphamide. There are few reports of patients with liver metastasis having radiological findings mimicking cirrhosis, both in the presence or the absence of prior systemic chemotherapy. Hepatotoxicity of antineoplastic drugs and cellular necrosis induced by response of liver metastases to chemotherapy may play a critical role in its physiopathology. MATERIALS AND METHODS: This article reports a series of ten women with breast cancer (nine with liver metastasis) treated with chemotherapy or hormonotherapy. RESULTS: They had low risk factors for hepatic disease, but developed a cirrhosis-like appearance in the computed tomography scan. The patient without liver metastasis is the second of this kind described in the literature. Relatively few reports have documented clinical sequelae of portal hypertension. In our series, three patients had oesophageal bleeding varices needing be hospitalised. To our knowledge, these are the first cases reported in the literature. CONCLUSIONS: This suggests that some manifestations of portal hypertension may develop in association with the cirrhosis- like pattern induced by breast cancer therapy (AU)


No disponible


Subject(s)
Humans , Female , Middle Aged , Aged , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Hypertension, Portal/etiology , Hypertension, Portal/physiopathology , Magnetic Resonance Imaging/methods , Tomography, X-Ray Computed/methods , Tomography, X-Ray Computed
6.
Oncología (Barc.) ; 26(1): 19-27, ene. 2003. tab, graf
Article in Es | IBECS | ID: ibc-21589

ABSTRACT

Propósito: comparar la eficacia, toxicidad y tasa de complicaciones quirúrgicas del tratamiento adyuvante frente al tratamiento neoadyuvante en el carcinoma de recto.• Material y métodos: 111 pacientes con carcinoma de recto estadios II-III recibieron tratamiento complementario con radioterapia (RT) y quimioterapia (QT). La QT consistió en leucovorin (500 mg/m2) intravenoso el primer día, seguido de lencovorin oral 15 mg/12 horas entre los días 2 y 14 del ciclo, y UFT 390 mg/m2/día entre los días 1 y 14 (350 mg/m2 durante la RT) . En 32 enfermos el tratamiento se realizó de forma neoadyuvante (grupo N), mientras que en los 79 restantes se administró tras la cirugía (grupo A).• Resultados: no hubo diferencias significativas en la supervivencia libre de enfermedad (72 por ciento en el grupo A y 69 por ciento en el grupo N) ni en la supervivencia global a los 3 años (91 por ciento en el grupo A y 95 por ciento en el grupo N). La tasa de complicaciones mayores tras la cirugía fue similar en ambos grupos. La tasa de diarrea grado 3-4 fue del 43 por ciento en los primeros 14 pacientes del grupo N (que recibieron UFT 350 mg/m2), mientras que en el grupo A fue del 18 por ciento (Fisher, p=0.07). En los restantes 18 pacientes del grupo N la dosis de UFT fue reducida a 300 mg/m2. La tasa de cirugía conservadora de esfínter en los tumores situados en los 10 cm últimos del recto fue superior en el grupo N (53 por ciento vs 38 por ciento, p=n.s.).• Conclusiones: el tratamiento neoadyuvante en el cáncer de recto no presenta diferencias significativas con el tratamiento adyuvante en cuanto a tasa de complicaciones quirúrgicas, tasa de recaídas y supervivencia, pero sí aumenta la toxicidad gastrointestinal. (AU)


Subject(s)
Adult , Aged , Female , Male , Middle Aged , Humans , Rectal Neoplasms/therapy , Preoperative Care/methods , Postoperative Care/methods , Carcinoma/therapy , Chemotherapy, Adjuvant , Leucovorin/administration & dosage , Survival Rate , Postoperative Complications/epidemiology , Cobalt Radioisotopes/therapeutic use , /epidemiology , Neoplasm Recurrence, Local/epidemiology
7.
An Med Interna ; 19(9): 457-9, 2002 Sep.
Article in Spanish | MEDLINE | ID: mdl-12420630

ABSTRACT

Lymphomas of the gastrointestinal tract are the most common type of primary extranodal lymphomas and about 15-20% of these are primary intestinal lymphomas. They may be or B or T- cell. Intestinal T-cell lymphomas are much less common and they can be enteropathy-associated. This disease occurs in adults with abdominal pain often associated with intestinal perforation. The course is aggressive. The major problem is to distinguish this disease from a benign ulcer. Two cases with differents clinical and pathologic features are reported with a review in the literature of this uncommon entity.


Subject(s)
Intestinal Neoplasms/pathology , Lymphoma, T-Cell/pathology , Adult , Humans , Intestinal Neoplasms/diagnosis , Lymphoma, T-Cell/diagnosis , Male , Middle Aged
8.
An. med. interna (Madr., 1983) ; 19(9): 457-459, sept. 2002.
Article in Es | IBECS | ID: ibc-17183

ABSTRACT

Los linfomas del tracto gastrointestinal son el tipo más frecuente de linfomas extraganglionares y de éstos el 15-20 per cent son de localización intestinal. Pueden ser B o T. Los linfomas tipo T son menos comunes y pueden estar o no asociados a enteropatía. Suelen aparecer en adultos en forma de dolor abdominal a menudo asociado a perforación intestinal. El curso es agresivo. El mayor problema es hacer el diagnóstico diferencial con las úlceras benignas. Se presentan dos casos de diferentes características y evolución y que permiten realizar una revisión de las características clinicopatológicas de esta rara entidad. (AU)


Subject(s)
Middle Aged , Adult , Male , Humans , Lymphoma, T-Cell , Intestinal Neoplasms
9.
Oncología (Barc.) ; 25(3): 180-183, mar. 2002. ilus
Article in Es | IBECS | ID: ibc-13802

ABSTRACT

Propósito: Se presenta un caso de tumor testicular fundido que se manifiesta de forma atípica con múltiples metástasis hepáticas y pulmonares. Se analiza el diagnóstico diferencial con el tumor germinal extragonadal y su importancia clínica. Observación clínica: Varón de 42 años que debuta con lesiones pulmonares y hepáticas de origen desconocido. La necropsia demostró metástasis de tumor germinal mixto (coriocarcinoma y carcinoma embrionario) y una fibrosis tubulo-intersticial en el testículo derecho. Conclusiones: En todo varón joven con sospecha de enfermedad tumoral, especialmente si la evolución clínica es rápida, hay que plantearse la posibilidad de un tumor germinal y descartar, mediante ecografía y eventual estudio histológico, la presencia de una neoplasia testicular (AU)


Subject(s)
Adult , Male , Humans , Choriocarcinoma/pathology , Lung Neoplasms/secondary , Testicular Neoplasms/pathology , Liver Neoplasms/secondary , Diagnosis, Differential , Fatal Outcome
10.
Oncología (Barc.) ; 24(7): 372-375, jul. 2001. ilus, tab
Article in Es | IBECS | ID: ibc-15311

ABSTRACT

Propósito: El linfoma primario óseo es una rara forma de linfoma extranodal que representa menos de un 1 por ciento de los linfomas no Hodgkin. Su diagnóstico puede ser difícil por los síntomas de presentación y las características radiológicas, a veces similares a las de otras enfermedades óseas. En general tiene un buen pronóstico tras el tratamiento aunque éste no ha sido completamente definido. Material y métodos: Se presentan dos pacientes que presentaron esta enfermedad pero con distintas edades, síntomas y localización del tumor. Resultados y conclusiones: Estos casos permiten tener la oportunidad de revisar esta infrecuente neoplasia que tiene una supervivencia libre de enfermedad a los ocho años cercana al 100 por ciento (AU)


Subject(s)
Adult , Aged , Female , Male , Humans , Lymphoma, Non-Hodgkin , Review
11.
Oncología (Barc.) ; 24(4): 185-191, abr. 2001. tab
Article in Es | IBECS | ID: ibc-15264

ABSTRACT

La evaluación económica ha ido adquiriendo una gran importancia dentro de la Medicina y se han desarrollado diferentes estudios famacoeconómicos con distinto impacto en la práctica clínica. Los costes directos de los enfermos con cáncer se sitúan en torno a un 10 porciento del total de los costes médicos por lo que este énfasis ha influido también en los estudios oncológicos. Desafortunadamente, a pesar del aumento de los análisis económicos publicados en la literatura, es difícil saber todavía cuál es el impacto real en Oncología. En este articulo se revisan los conceptos básicos de farmacoeconomía y una visión general de su aplicación en la práctica oncológica (AU)


Subject(s)
Humans , Economics, Pharmaceutical/trends , Medical Oncology/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...